Cyclosporin inhibits hyperalgesia and edema in arthritic rats: Role of the central nervous system

Brazilian Journal of Medical and Biological Research

Volumn 30, Issue 1, 1997, Pages 101-111

  Francischi, J N ^a   Pereira, L S M ^a   Castro, M S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

adjuvant arthritis; cyclosporin; edema; hyperalgesia

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; DEXAMETHASONE;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG THERAPY; FEMALE; HYPERALGESIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; RAT;

ANIMALIA; MYCOBACTERIUM;

EID: 0031057714     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-879X1997000100016     Document Type: Article

References (41)

1. Owen RT (1980). Adjuvant induced polyarthritis - an overview. Methods and Findings in Experimental and Clinical Pharmacology, 2: 199-204.
2. Pearson CM (1956). Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proceedings of the Society for Experimental Biology and Medicine, 91: 95-101.
3. Pearson CM & Wood F (1963). Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvant. American Journal of Pathology, 42: 93-95.
4. Stoerck HD, Bielinski TC & Budzilovich T (1954). Chronic polyarthritis in rats injected with spleen in adjuvants. American Journal of Pathology, 30: 616A.
5. Van Arman GC (1976). Pathway to adjuvant arthritis. Federation Proceedings, 35: 2442-2446.
6. Colpaert FC, Meert T, De Witthand P & Schmitt P (1982). Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat. Life Sciences, 31: 67-75.
7. Pearson CM & Chang TY (1977). The contribution of adjuvant arthritis to the recognition of antirheumatic drugs. In: Dumonde DC & Jasane JK (Editors), Recognition of Anti-Rheumatic Drugs. MTP Press Limited, Lancaster, 229-239.
8. Binderup L (1983). Decreased T-suppressor cell activity in rats with adjuvant arthritis. Annals of the Rheumatic Diseases, 42: 693-698.
9. Waksman BH, Pearson CM & Sharp JT (1960). Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that disease is a disseminated immunologic response to exogenous antigen. Journal of Immunology, 85: 403-417.
10. Carlson RP, Hartman DA, Tomcheck LA, Walter TL, Lugay JR, Calhoun W, Sehgal SN & Chang JY (1993). Rapamycin, a potent disease-modifying antiarthritic drug. Journal of Pharmacology and Experimental Therapeutics, 266: 1125-1138.
11. Faulds D, Goa KL & Benfiel P (1993). Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in immunoregulatory disorders. Drugs, 45: 953-1040.
12. Morris WR (1992). Rapamycins: antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transplantation Reviews, 6: 39-87.
13. Sigal NH & Dumont FJ (1992). Cyclosporin A, FK-506, and rapamycin: pharmacological probes of lymphocyte signal transduction. Annual Review of Immunology, 10: 519-559.
14. Burnstein KL & Cidlowski JA (1989). Regulation of gene expression by glucocorticoids. Annual Review of Physiology, 51: 683-699.
15. Sternberg EM & Wilder RL (1993). Corticosteroids. In: McCarty DJ and Koopman WJ (Editors), Arthritis and Allied Conditions. Vol. I. Lea & Febiger, Philadelphia, 665-682.
16. Capetola JR, Shriver AD & Rosenthale EM (1980). Suprofen, a new peripheral analgesic. Journal of Pharmacology and Experimental Therapeutics, 214: 16-23.
17. Pircio AW, Fedele CT & Bierwage ME (1975). A new method for the evaluation of analgesic activity using adjuvant-induced arthritis in the rat. European Journal of Pharmacology, 31: 207-215.
18. Tatsuo MAKF, Carvalho WM, Silva CV, Miranda AEG, Ferreira SH & Francischi JN (1994). Analgesic and antiinflamatory effects of dipyrone in rat adjuvant arthritis model. Inflammation, 18: 399-405.
19. Lemaire M, Pardridge WM & Chaudhuri G (1988). Influence of blood components on the tissue uptake indices of cyclosporin in rats. Journal of Pharmacology and Experimental Therapeutics, 244: 740-743.
20. Konig JFR & Klippel RA (1974). The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Krieger Publishing Co. Inc., New York.
21. Johnston A, Marsden JT & Holt DW (1989). The continuing need for quality assessment of cyclosporin measurement. Clinical Chemistry, 35: 1309-1312.
22. 3H] radioimmunoassay with a monoclonal antibody for monitoring cyclosporin in blood. Clinical Chemistry, 34: 257-261.
23. Connolly KM, Stecher VJ, Danis E, Pruden D & Jandlabrien T (1988). Alteration of interleukin 1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin A or methotrexate. International Journal of Immunopharmacology, 10: 717-728.
24. Del Pozo E, Elford P, Perrelet R, Graeber M, Cazez PJ, Modrowski D, Payne T & Mackenzie AR (1992). Prevention of arthritis by cyclosporine in rats. Seminars in Arthritis and Rheumatism, 21: 23-29.
25. Jaffe BD, Kerr JS, Jones EA, Giannaras JV, McGowan M & Ackerman NR (1989). The effect of immunomodulating drugs on adjuvant-induced arthritis in Lewis rats. Agents and Actions, 27: 345-346.
26. Cunningham Jr ETC & De Souza EB (1993). Interleukin 1 receptors in the brain and endocrine tissues. Immunology Today, 14: 171-176.
27. Dinarello CA (1991). Interleukin 1. In: Thomson AW (Editor), The Cytokine Handbook. Academic Press, San Diego, 47-82.
28. Eastgate JA, Symons JA, Wood NC, Grilinton FM, Giovani FS & Duff GW (1988). Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet, 2: 706-709.
29. Nouri AME, Panayi GS & Goodman SM (1984). Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clinical and Experimental Immunology, 55: 295-302.
30. Pugh-Humphreys RGP, Woo J & Thomson AW (1991). Cytokines and their receptors as potential therapeutic targets. In: Thomson AW (Editor), The Cytokine Handbook. Academic Press, San Diego, 357-386.
31. 2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. British Journal of Pharmacology, 113: 63-68.
32. Ferreira SH, Lorenzetti BB, Bristow AF & Poole S (1988). Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature, 334: 698-700.
33. Rao A (1994). NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunology Today, 15: 274-281.
34. Tugwell P, Bombardier C, Gent M, Bennee KJ, Bensen WG, Carette S, Chalmers A, Esdaile JM, Klinkhoff AV, Kraag GR, Ludwin D & Roberts RS (1990). Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet, 335: 1051-1055.
35. Yocum DE, Wilder RL, Dougherty S, Klippel JH, Pillemer S & Wahl S (1990). Immunologic parameters of response in patients with rheumatoid arthritis treated with cyclosporin A. Arthritis and Rheumatism, 33: 1310-1316.
36. Wutrich K, Von Freyberg B, Weber C, Wilder G, Traber R, Widmer H & Braun W (1991). Receptor-induced conformation change of the immunosuppressant cyclosporin A. Science, 254: 953-954.
37. Fazakerley JK & Webb HE (1985). Cyclosporin, blood-brain barrier, and multiple sclerosis. Lancet, 19: 889-890.
38. Groen PC, Aksamit ALJ, Rakela J, Forbes GS & Krom RAF (1987). Central nervous system toxicity after liver transplantation. The role of cyclosporin and cholesterol. New England Journal of Medicine, 317: 861-866.
39. Widner H & Brundin P (1988). Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Research Reviews, 13: 287-324.
40. Owens T, Renno T, Taupim V & Krakowski M (1994). Inflammatory cytokines in the brain: does the CNS shape immune responses? Immunology Today, 15: 566-571.
41. Cserr HF & Knopf PM (1992). Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunology Today, 13: 507-512.